EGFR is known to hyperactivate the phosphatidylinositol 3 kinase (PI3K)/AKT signaling pathway, which has been demonstrated to be involved in the regulation of GBM cell survival, proliferation, and motility [23]. This evidence concerns the gene EGFR and glioblastoma.